Skip to main content
SpringerLink
Log in

Medicaid Preferred Drug Lists: Cost Containment and Side Effects

  • Introduction
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Medicare and Medicaid. Rationale for Medicare Part D protected classes. Available at URL: http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/FormularyGuidanceAllorSubAll.pdf [Accessed: 12 November 2006].

  2. Mucha L, Masia NA, Axelsen KJ. Per-patient-per-month drug costs in Medicare Part D protected classes. PharmacoEconomics 2006; 24 (Suppl 3): 79–84

    Article  PubMed  Google Scholar 

  3. Lichtenberg FR. The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003. PharmacoEconomics 2006; 24 (Suppl 3): 5–25

    Article  PubMed  Google Scholar 

  4. Abdelgawad TA, Egbuonu-Davis L. Preferred drug lists and Medicaid prescriptions. PharmacoEconomics 2006; 24 (Suppl 3): 55–63

    Article  PubMed  Google Scholar 

  5. Ridley DB, Axelsen KJ. Impact of Medicaid preferred drug lists on therapeutic adherence. PharmacoEconomics 2006; 24 (Suppl 3): 65–78

    Article  PubMed  Google Scholar 

  6. Ketcham JD, Epstein AJ. Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives? PharmacoEconomics 2006; 24 (Suppl 3): 27–40

    Article  PubMed  Google Scholar 

  7. Headen AE, Masia NA, Axelsen KJ. Effects of Medicaid access restrictions on statin utilisation for patients seeing physicians practising in poor and minority neighbourhoods. PharmacoEconomics 2006; 24 (Suppl 3): 41–53

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Economics, College of Management, North Carolina State University, Nelson Hall 4164, Box 8110, Raleigh, North Carolina, 27695-8110, USA

    Alvin E. Headen Jr

Authors
  1. Alvin E. Headen Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alvin E. Headen Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Headen, A.E. Medicaid Preferred Drug Lists: Cost Containment and Side Effects. PharmacoEconomics 24 (Suppl 3), 1–3 (2006). https://doi.org/10.2165/00019053-200624003-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200624003-00001

Search

Navigation